Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study-Reference-Cited by-同舟云学术

Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study

Published:2014-08 Issue:9 Volume:15 Page:954-965
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ribas Antoni,Gonzalez Rene,Pavlick Anna,Hamid Omid,Gajewski Thomas F,Daud Adil,Flaherty Lawrence,Logan Theodore,Chmielowski Bartosz,Lewis Karl,Kee Damien,Boasberg Peter,Yin Ming,Chan Iris,Musib Luna,Choong Nicholas,Puzanov Igor,McArthur Grant A

Publisher

Elsevier BV

Subject

Oncology

Reference22 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

3. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy;Shi;Cancer Discov,2014

4. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma;Trunzer;J Clin Oncol,2013

5. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma;Van Allen;Cancer Discov,2014

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation;Cells;2024-09-09

2. Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?;European Journal of Cancer;2024-09

3. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

4. Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol;Cellular and Molecular Life Sciences;2024-05-22

5. Diagnostic and Therapeutic Particularities of Symptomatic Melanoma Brain Metastases from Case Report to Literature Review;Diagnostics;2024-03-25